Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 1/2009

01-01-2009 | 2008 ssat plenary presentation

Practical Limitations of Bioresorbable Membranes in the Prevention of Intra-Abdominal Adhesions

Authors: Rizal Lim, Jonathan M. Morrill, Ryan C. Lynch, Karen L. Reed, Adam C. Gower, Susan E. Leeman, Arthur F. Stucchi, James M. Becker

Published in: Journal of Gastrointestinal Surgery | Issue 1/2009

Login to get access

Abstract

Introduction

Intra-abdominal adhesions are a significant source of postoperative morbidity. Bioresorbable barriers composed of hyaluronic acid and carboxymethylcellulose (HA/CMC) reduce adhesion formation by physically separating injured or healing peritoneal surfaces. To assess whether the efficacy of a physical barrier can extend beyond the site of application, we evaluated the effectiveness of an HA/CMC barrier in preventing adhesions distal to the site of placement.

Methods

Adhesions were induced in rats by creating peritoneal ischemic buttons on either side of a midline incision. An HA/CMC barrier (Seprafilm™ Genzyme) was intraoperatively placed either under the midline incision, unilaterally over half the ischemic buttons, or bilaterally over all ischemic buttons. Control buttons received no HA/CMC. On day 7 adhesions were scored. In similar experiments, peritoneal fluid was collected at 24 h to assess the effects of HA/CMC on tissue plasminogen activator activity.

Results

Placement of HA/CMC under the midline incision did not reduce adhesion formation to distal ischemic buttons (72 ± 7%) compared to controls (80 ± 8%). Unilateral placement of HA/CMC significantly (p < 0.05) reduced adhesion formation to those ischemic buttons over which the barrier was applied (35 ± 7%) compared to both contralateral (83 ± 9%) and control (80 ± 8%) ischemic buttons. The bilateral application of HA/CMC also significantly (p < 0.05) reduced adhesion formation to all ischemic buttons compared to controls (22 ± 7% vs. 66 ± 7%, respectively). HA/CMC did not affect peritoneal tPA activity.

Conclusions

Effective adhesion reduction by the physical barrier HA/CMC appears to be limited to the site of application in this rat model. Despite the presence of a bioresorbable membrane at predicted sites of adhesion formation in the peritoneal cavity, adhesions readily form to distal unprotected sites.
Literature
3.
go back to reference Parker MC, Wilson MS, van Goor H, Moran BJ, Jeekel J, Duron JJ, et al. Adhesions and colorectal surgery—call for action. 2007;9:66–72. Parker MC, Wilson MS, van Goor H, Moran BJ, Jeekel J, Duron JJ, et al. Adhesions and colorectal surgery—call for action. 2007;9:66–72.
6.
go back to reference Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg. 2001;18:260–273. doi:10.1159/000050149.PubMedCrossRef Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg. 2001;18:260–273. doi:10.​1159/​000050149.PubMedCrossRef
8.
go back to reference Menzies D, Parker M, Hoare R, Knight A. Small bowel obstruction due to postoperative adhesions: treatment patterns and associated costs in 110 hospital admissions. Ann R Coll Surg Engl. 2001;83:40–46.PubMed Menzies D, Parker M, Hoare R, Knight A. Small bowel obstruction due to postoperative adhesions: treatment patterns and associated costs in 110 hospital admissions. Ann R Coll Surg Engl. 2001;83:40–46.PubMed
9.
go back to reference Tingstedt B, Andersson E, Isaksson K, Andersson R. Clinical impact of abdominal adhesions: What is the magnitude of the problem? Scand J Gastroenterol. 2008;43(3):255–261.PubMedCrossRef Tingstedt B, Andersson E, Isaksson K, Andersson R. Clinical impact of abdominal adhesions: What is the magnitude of the problem? Scand J Gastroenterol. 2008;43(3):255–261.PubMedCrossRef
12.
go back to reference Wiseman DM. Adhesion Prevention: Past the Future. In diZerega GS, ed. Peritoneal Surgery. New York: Springer, 2000, pp 401–417. Wiseman DM. Adhesion Prevention: Past the Future. In diZerega GS, ed. Peritoneal Surgery. New York: Springer, 2000, pp 401–417.
13.
go back to reference Burns JW, Colt MJ, Burgees LS, Skinner KC. Preclinical evaluation of Seprafilm bioresorbable membrane. Eur J Surg Suppl. 1997;577:40–8.PubMed Burns JW, Colt MJ, Burgees LS, Skinner KC. Preclinical evaluation of Seprafilm bioresorbable membrane. Eur J Surg Suppl. 1997;577:40–8.PubMed
14.
go back to reference Becker JM, Dayton MT, Fazio VW, Beck DE, Stryker SJ, Wexner SD, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg. 1996;183:297–306. see comments.PubMed Becker JM, Dayton MT, Fazio VW, Beck DE, Stryker SJ, Wexner SD, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg. 1996;183:297–306. see comments.PubMed
15.
16.
go back to reference Hayashi S, Takayama T, Masuda H, Kochi M, Ishii Y, Matsuda M, et al. Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: a randomized clinical trial. Ann Surg. 2008;247:766–770. doi:10.1097/SLA.0b013e3181656d4e.PubMedCrossRef Hayashi S, Takayama T, Masuda H, Kochi M, Ishii Y, Matsuda M, et al. Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: a randomized clinical trial. Ann Surg. 2008;247:766–770. doi:10.​1097/​SLA.​0b013e3181656d4e​.PubMedCrossRef
20.
go back to reference Holmdahl L.. The role of fibrinolysis in adhesion formation. Eur J Surg Suppl 1997;577:24–31.PubMed Holmdahl L.. The role of fibrinolysis in adhesion formation. Eur J Surg Suppl 1997;577:24–31.PubMed
22.
go back to reference Binnebosel M, Rosch R, Junge K, Lynen-Jansen P, Schumpelick V, Klinge U. Macrophage and T-lymphocyte infiltrates in human peritoneal adhesions indicate a chronic inflammatory disease. World J Surg. 2008;32:296–304. doi:10.1007/s00268-007-9330-x.PubMedCrossRef Binnebosel M, Rosch R, Junge K, Lynen-Jansen P, Schumpelick V, Klinge U. Macrophage and T-lymphocyte infiltrates in human peritoneal adhesions indicate a chronic inflammatory disease. World J Surg. 2008;32:296–304. doi:10.​1007/​s00268-007-9330-x.PubMedCrossRef
25.
go back to reference Reed KL, Fruin AB, Bishop-Bartolomei KK, Gower AC, Nicolaou M, Stucchi AF, et al. Neurokinin-1 receptor and substance P messenger RNA levels increase during intraabdominal adhesion formation. J Surg Res. 2002;108:165–172. doi:10.1006/jsre.2002.6533.PubMedCrossRef Reed KL, Fruin AB, Bishop-Bartolomei KK, Gower AC, Nicolaou M, Stucchi AF, et al. Neurokinin-1 receptor and substance P messenger RNA levels increase during intraabdominal adhesion formation. J Surg Res. 2002;108:165–172. doi:10.​1006/​jsre.​2002.​6533.PubMedCrossRef
26.
go back to reference Cohen PA, Aarons CB, Gower AC, Stucchi AF, Leeman SE, Becker JM, et al. The effectiveness of a single intraperitoneal infusion of a neurokinin-1 receptor antagonist in reducing postoperative adhesion formation is time dependent. Surgery. 2007;141:368–375. doi:10.1016/j.surg.2006.09.007.PubMedCrossRef Cohen PA, Aarons CB, Gower AC, Stucchi AF, Leeman SE, Becker JM, et al. The effectiveness of a single intraperitoneal infusion of a neurokinin-1 receptor antagonist in reducing postoperative adhesion formation is time dependent. Surgery. 2007;141:368–375. doi:10.​1016/​j.​surg.​2006.​09.​007.PubMedCrossRef
28.
go back to reference Fazio VW, Cohen Z, Fleshman JW, van Goor H, Bauer JJ, Wolff BG, et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum. 2006;49:1–11. doi:10.1007/s10350-005-0268-5.PubMedCrossRef Fazio VW, Cohen Z, Fleshman JW, van Goor H, Bauer JJ, Wolff BG, et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum. 2006;49:1–11. doi:10.​1007/​s10350-005-0268-5.PubMedCrossRef
29.
go back to reference Reed KL, Fruin AB, Gower AC, Stucchi AF, Leeman SE, Becker JM. A neurokinin 1 receptor antagonist decreases postoperative peritoneal adhesion formation and increases peritoneal fibrinolytic activity. Proc Natl Acad Sci U S A. 2004;101:9115–9120. doi:10.1073/pnas.0403210101.PubMedCrossRef Reed KL, Fruin AB, Gower AC, Stucchi AF, Leeman SE, Becker JM. A neurokinin 1 receptor antagonist decreases postoperative peritoneal adhesion formation and increases peritoneal fibrinolytic activity. Proc Natl Acad Sci U S A. 2004;101:9115–9120. doi:10.​1073/​pnas.​0403210101.PubMedCrossRef
33.
go back to reference Heydrick SJ, Reed KL, Cohen PA, Aarons CB, Gower AC, Becker JM, et al. Intraperitoneal administration of methylene blue attenuates oxidative stress, increases peritoneal fibrinolysis, and inhibits intraabdominal adhesion formation. J Surg Res. 2007;143:311–319. doi:10.1016/j.jss.2006.11.012.PubMedCrossRef Heydrick SJ, Reed KL, Cohen PA, Aarons CB, Gower AC, Becker JM, et al. Intraperitoneal administration of methylene blue attenuates oxidative stress, increases peritoneal fibrinolysis, and inhibits intraabdominal adhesion formation. J Surg Res. 2007;143:311–319. doi:10.​1016/​j.​jss.​2006.​11.​012.PubMedCrossRef
Metadata
Title
Practical Limitations of Bioresorbable Membranes in the Prevention of Intra-Abdominal Adhesions
Authors
Rizal Lim
Jonathan M. Morrill
Ryan C. Lynch
Karen L. Reed
Adam C. Gower
Susan E. Leeman
Arthur F. Stucchi
James M. Becker
Publication date
01-01-2009
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 1/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-008-0724-3

Other articles of this Issue 1/2009

Journal of Gastrointestinal Surgery 1/2009 Go to the issue